[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @mirumpharma Mirum Pharmaceuticals Mirum Pharmaceuticals posts on X about delta, acquisition, strong the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours. ### Engagements: XX [#](/creator/twitter::1085339805909581824/interactions)  - X Months XXX +208% - X Year XXX +125% ### Mentions: X [#](/creator/twitter::1085339805909581824/posts_active)  ### Followers: XXX [#](/creator/twitter::1085339805909581824/followers)  - X Months XXX +11% - X Year XXX +15% ### CreatorRank: undefined [#](/creator/twitter::1085339805909581824/influencer_rank)  ### Social Influence **Social category influence** [finance](/list/finance) **Social topic influence** [delta](/topic/delta) #673, [acquisition](/topic/acquisition), [strong](/topic/strong) **Top accounts mentioned or mentioned by** [@thegfpd](/creator/undefined) [@huntershopefdn](/creator/undefined) [@ulfunited](/creator/undefined) [@ctxalliance](/creator/undefined) [@casahunterbr](/creator/undefined) [@apmpsvida](/creator/undefined) [@aidanslaw](/creator/undefined) [@pscpartners](/creator/undefined) [@pscpartnersca](/creator/undefined) [@pscsupportuk](/creator/undefined) [@europeliver](/creator/undefined) [@hetzliver](/creator/undefined) [@bareincorg](/creator/undefined) ### Top Social Posts Top posts by engagements in the last XX hours "Today we announced a definitive agreement to acquire Bluejay Therapeutics driven by the opportunity to further advance the development of their Breakthrough Therapy and PRIME-designated late-stage investigational monoclonal antibody brelovitug for chronic hepatitis delta virus (HDV) an underserved rare disease with no FDA-approved therapies. This acquisition represents an important step in expanding Mirums rare disease portfolio. We look forward to engaging with the HDV community and bringing brelovitug forward with the same patient-centered approach and disciplined execution that guides our" [X Link](https://x.com/mirumpharma/status/1998015262260351146) 2025-12-08T13:02Z XXX followers, XXX engagements "Our agreement to acquire Bluejay Therapeutics reflects our disciplined approach to advancing meaningful therapies in rare disease including the opportunity to further develop brelovitug for chronic hepatitis delta virus (HDV). We see strong promise in brelovitug for patients with HDV a population facing a severe burden of disease and few therapeutic options and we remain committed to thoughtful innovation and delivering high-impact medicines for the HDV community. Learn more about the announcement:" [X Link](https://x.com/mirumpharma/status/1998046951833563287) 2025-12-08T15:08Z XXX followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@mirumpharma Mirum PharmaceuticalsMirum Pharmaceuticals posts on X about delta, acquisition, strong the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours.
Social category influence finance
Social topic influence delta #673, acquisition, strong
Top accounts mentioned or mentioned by @thegfpd @huntershopefdn @ulfunited @ctxalliance @casahunterbr @apmpsvida @aidanslaw @pscpartners @pscpartnersca @pscsupportuk @europeliver @hetzliver @bareincorg
Top posts by engagements in the last XX hours
"Today we announced a definitive agreement to acquire Bluejay Therapeutics driven by the opportunity to further advance the development of their Breakthrough Therapy and PRIME-designated late-stage investigational monoclonal antibody brelovitug for chronic hepatitis delta virus (HDV) an underserved rare disease with no FDA-approved therapies. This acquisition represents an important step in expanding Mirums rare disease portfolio. We look forward to engaging with the HDV community and bringing brelovitug forward with the same patient-centered approach and disciplined execution that guides our"
X Link 2025-12-08T13:02Z XXX followers, XXX engagements
"Our agreement to acquire Bluejay Therapeutics reflects our disciplined approach to advancing meaningful therapies in rare disease including the opportunity to further develop brelovitug for chronic hepatitis delta virus (HDV). We see strong promise in brelovitug for patients with HDV a population facing a severe burden of disease and few therapeutic options and we remain committed to thoughtful innovation and delivering high-impact medicines for the HDV community. Learn more about the announcement:"
X Link 2025-12-08T15:08Z XXX followers, XX engagements
/creator/twitter::mirumpharma